Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular therapy in the newborn.

G G Sandor

    Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
    |January 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    This study reviews newborn heart treatments, discussing inotropic agents like digoxin and dopamine. It also covers Prostaglandin-E

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Response to: echocardiography assessment of the aorta in children with chronic kidney disease.

    Pediatric cardiology·2014
    Same author

    Interrupted right aortic arch and origin of the left pulmonary artery from the aorta in DiGeorge syndrome.

    Cardiology in the young·2002
    Same author

    Balloon angioplasty of right ventricular outflow tract conduits.

    Pediatric cardiology·2001
    Same author

    Echocardiography and pulmonary function testing in childhood onset systemic lupus erythematosus.

    Lupus·2001
    Same author

    Postpericardiotomy syndrome: no evidence for a viral etiology.

    Cardiology in the young·2001
    Same author

    Coil occlusion of the patent ductus arteriosus: lessons learned.

    Cardiovascular and interventional radiology·2000

    Area of Science:

    • Neonatal cardiology
    • Pediatric pharmacology
    • Congenital heart disease

    Background:

    • Congenital heart defects in newborns often involve the ductus arteriosus.
    • Maintaining ductal patency is crucial in certain neonatal conditions.
    • Inotropic support is vital for managing neonatal cardiac dysfunction.

    Purpose of the Study:

    • To discuss the application of key inotropic agents in neonatal care.
    • To outline the role of Prostaglandin-E in ductus arteriosus management.
    • To explore methods for ductal closure before surgical intervention.

    Main Methods:

    • Review of current literature on neonatal inotropic therapy.
    • Analysis of Prostaglandin-E's mechanism in ductal patency.
    • Examination of pharmacological strategies to inhibit prostaglandin synthesis.

    Related Experiment Videos

    Main Results:

    • Digoxin and dopamine are principal inotropic agents for newborns.
    • Prostaglandin-E is essential for maintaining ductal patency in anomalous vessel formation.
    • Inhibiting prostaglandin production can facilitate ductal closure pre-surgery.

    Conclusions:

    • Appropriate use of inotropic agents is critical for neonatal cardiac support.
    • Understanding Prostaglandin-E's role informs treatment of ductal-dependent lesions.
    • Pharmacological ductal closure offers a therapeutic option prior to surgical correction.